AI Summary
We reviewed 75 live results for infliximab infusion and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Rheumatology and Immunology.
We reviewed 75 live results for infliximab infusion and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Rheumatology and Immunology.
Source: Samitivej Hospital
Description
A biologic DMARD (TNF inhibitor) administered as an intravenous infusion (100 mg sterile powder). This service is typically provided in a hospital setting for patients with rheumatoid arthritis requiring intensive biologic therapy.
Best for
intravenous infusion therapy, biologic DMARD treatment, TNF inhibitor access and hospital-based medical care
Rating
Source: National University Hospital (NUH)
Description
Specialized intravenous immunoglobulin (IVIG) infusion service using Flebogamma DIF (5% and 10%) as part of the hospital's drug formulary. The treatment is administered by trained healthcare professionals for patients with immunodeficiency or immunomodulatory requirements.
Best for
tertiary care patients, specialized IVIG infusion, hospital formulary drug access and immunological disorders
Rating
Source: Celltrion Healthcare Philippines Inc.
Description
Remsima is a biosimilar for treating autoimmune diseases such as Crohn’s disease and Rheumatoid Arthritis.
Best for
Crohn’s disease patients, Rheumatoid Arthritis and autoimmune disease management
Rating
| Compare | Infliximab Infusion | Flebogamma DIF Infusion Therapy | Remsima (Infliximab) |
|---|---|---|---|
| Source | Samitivej Hospital | National University Hospital (NUH) | Celltrion Healthcare Philippines Inc. |
| Description | A biologic DMARD (TNF inhibitor) administered as an intravenous infusion (100 mg sterile powder). This service is typically provided in a hospital setting for patients with rheumatoid arthritis requiring intensive biologic therapy. | Specialized intravenous immunoglobulin (IVIG) infusion service using Flebogamma DIF (5% and 10%) as part of the hospital's drug formulary. The treatment is administered by trained healthcare professionals for patients with immunodeficiency or immunomodulatory requirements. | Remsima is a biosimilar for treating autoimmune diseases such as Crohn’s disease and Rheumatoid Arthritis. |
| Best for | intravenous infusion therapy, biologic DMARD treatment, TNF inhibitor access and hospital-based medical care | tertiary care patients, specialized IVIG infusion, hospital formulary drug access and immunological disorders | Crohn’s disease patients, Rheumatoid Arthritis and autoimmune disease management |
| Tags | |||
| Action | View Details | View Details | View Details |
| Rating |
If you want the most balanced option to start with, I recommend:
"Infliximab Infusion from Samitivej Hospital."
I picked this because Ideal for patients requiring hospital-monitored biologic infusion therapy for rheumatoid arthritis management.